Toledano A, Rodríguez-Arellano J J, Gómez de Segura I A, De Miguel E, Martínez-Rodríguez R
Cajal Institute, C.S.I.C., Madrid, Spain.
Cell Mol Biol (Noisy-le-grand). 1996 Dec;42(8):1145-58.
The influence of a bowel-trophic neurotensin (NT) treatment (13 days, 300 micrograms/kg/every 12 hrs.) on neurotensin-like immunopositive structures (neurons, fibres and epithelial-N-cells) and the neurotensin receptors (NTr) in the residual bowel after resection (90% small bowel or 75% colon) in the rat was studied using histochemical methods. Somatostatin-like (ST) immunopositive structures (neurons, fibres and epithelial-D-cells) and somatostatin receptors (STr) were also studied, comparatively. The results displayed a general increase of N-cells (11-17%) but not of D-cells, and a higher degree of variability section-to-section in the NT and ST immunopositive nervous structures (without increased density) after both resections, both with or without NT treatment. Receptors did not change after the small bowel resection but the colon resection and/or the NT treatment produced variations in the NT binding (from -24.3 to +16.85) in different intestinal regions. In a general sense, the variations among 1) the controls, 2) the resected animals, and 3) the resected and NT-treated animals, were of less extent (< or = 24%) than previously supposed for explaining the trophic effect of NT. Our results: a) confirm the autonomy, injury-resistance and tendency to maintain the physiological features of the bowel in very diverse situations; b) open new questions on both, the neurotensinergic changes after bowel resection and the mechanisms of the trophic effect of NT treatment, and c) suggest that, when neurotensin was applied as a trophic treatment in the cases of the need of a bowel resection, no important neurotensinergic or somatostatinergic side effects should be expected in the remaining bowel. However, the higher degree of variability section-to-section after surgery in the nervous structures was not modified by the NT treatment. This fact, and the different response of various intestinal regions to the NT treatment, suggest that functional problems in the remaining bowel could be maintained despite the growth of the mucosa induced by the NT treatment.
采用组织化学方法研究了肠营养性神经降压素(NT)治疗(13天,300微克/千克/每12小时)对大鼠小肠切除(90%小肠或75%结肠)后残留肠段中神经降压素样免疫阳性结构(神经元、纤维和上皮N细胞)及神经降压素受体(NTr)的影响。同时,对生长抑素样(ST)免疫阳性结构(神经元、纤维和上皮D细胞)及生长抑素受体(Str)进行了比较研究。结果显示,N细胞普遍增加(11%-17%),而D细胞未增加,且在两种切除术后,无论有无NT治疗,NT和ST免疫阳性神经结构在不同切片间的变异性更高(密度未增加)。小肠切除术后受体未发生变化,但结肠切除和/或NT治疗导致不同肠段的NT结合出现变化(从-24.3至+16.85)。总体而言,1)对照组、2)切除动物组和3)切除并经NT治疗动物组之间的差异程度(≤24%)小于先前认为的解释NT营养作用所需的程度。我们的研究结果:a)证实了肠在非常不同情况下的自主性、抗损伤性以及维持生理特征的倾向;b)对肠切除术后的神经降压素能变化及NT治疗的营养作用机制提出了新问题;c)表明,在需要进行肠切除的情况下将神经降压素作为营养治疗应用时,预计在剩余肠段中不会出现重要的神经降压素能或生长抑素能副作用。然而,NT治疗并未改变术后神经结构在不同切片间更高的变异性。这一事实以及不同肠段对NT治疗的不同反应表明,尽管NT治疗可诱导黏膜生长,但剩余肠段仍可能存在功能问题。